Safety of Biological Therapies in Elderly Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis

Background and Aim: Newer biologics appeared safer in landmark clinical trials, but their safety is understudied in vulnerable populations. The aim of the present study was to perform a systematic review and meta-analysis to assess the safety of available biologicals in the elderly IBD population. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Hahn, Gustavo Drügg, Golovics, Petra Anna, Wetwittayakhlang, Panu, Santa Maria, Dirlene Melo, Britto, Usiara, Wild, Gary Edward, Afif, Waqqas, Bitton, Alain, Bessissow, Talat, Lakatos, Peter Laszlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369299/
https://www.ncbi.nlm.nih.gov/pubmed/35956040
http://dx.doi.org/10.3390/jcm11154422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369299/
https://www.ncbi.nlm.nih.gov/pubmed/35956040
http://dx.doi.org/10.3390/jcm11154422

Ejemplares similares